切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2008, Vol. 02 ›› Issue (03) : 26 -29. doi: 10.3877/cma.j.issn.1674-0807.2008.03.008

综述

MicroRNA 在乳腺癌中的研究进展
黄关立1, 郭贵龙1, 张筱骅1   
  1. 1.325000 温州,温州医学院附属第一医院乳腺肿瘤中心
  • 收稿日期:2008-03-05 出版日期:2008-06-01

Progress in the study of microRNA in breast carcinoma

Guan-li HUANG, Gui-long GUO, Xiao-hua ZHANG   

  • Received:2008-03-05 Published:2008-06-01
引用本文:

黄关立, 郭贵龙, 张筱骅. MicroRNA 在乳腺癌中的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2008, 02(03): 26-29.

Guan-li HUANG, Gui-long GUO, Xiao-hua ZHANG. Progress in the study of microRNA in breast carcinoma[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2008, 02(03): 26-29.

关键词: MicroRNA, 乳腺癌
[1]
Lagos Quintana M, Rauhut R, Lendeckel W, et al.Identification of novel genes coding for small expressed RNAs.Science,2001,294:853 -858.
[2]
Lee R C, Feinbaum R L, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell,1993,75:843 -854.
[3]
Reinhart B J, Slack F J, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans.Nature,2000,403:901 -906.
[4]
Bartel D P. MicroRNAs: genomics, biogenesis, mechanism,and function. Cell,2004,116:281 -297.
[5]
Lewis B P, Burge C B, Bartel D P. Conserved seed pairing,often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell,2005,120:15 -20.
[6]
Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature,2005,436:214 -220.
[7]
PoyM N, Eliasson L, Krutzfeldt J, et al. A pancreatic isletspecific microRNA regulates insulin secretion. Nature,2004,432:226 -230.
[8]
Calin G A,Dumitru C D,Shimizu M,et al. Frequent deletions and down-regulation of micro-RNA genes mir15 and mir16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A,2002,99:15 524 -15 529.
[9]
Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.Cancer Cell,2006,9:189 -198.
[10]
Iorio M V, Ferracin M, Liu C G, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res,2005,65:7065 -7070.
[11]
Mattie M D, Benz C C, Bowers J, et al. Optimized highthroughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer,2006,5:24.
[12]
Blenkiron C, Goldstein L D, Thorne N P, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol,2007,8:R214.
[13]
Tavazoie S F, Alarcon C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis.Nature,2008,451:147 -152.
[14]
Volinia S, Calin GA, Liu C G, et al. A microRNA expression signature of human solid tumors defines cancer gene targets.Proc Natl Acad Sci U S A,2006,103:2257 -2261.
[15]
Zhu S, Si M L, Wu H, et al. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem,2007,282:14 328 -14 336.
[16]
Frankel L B, Christoffersen N R, Jacobsen A, et al.Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA mir-21 in Breast Cancer Cells. J Biol Chem,2008,283:1026 -1033.
[17]
Afonja O, Juste D, Das S, et al. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene,2004,23:8135 -8145.
[18]
Kenealy M R, Flouriot G, Sonntag-Buck V, et al. The 3'-untranslated region of the human estrogen receptor alpha gene mediates rapid messenger ribonucleic acid turnover.Endocrinology,2000,141:2805 -2813.
[19]
Adams B D, Furneaux H, White B A. The micro-ribonucleic acid (miRNA) mir-206 targets the human estrogen receptoralpha (ER alpha) and represses ER alpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol,2007,21:1132 -1147.
[20]
Ma L, Teruya Feldstein J, Weinberg R A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.Nature,2007,449:682 -688.
[21]
Cillo C, Cantile M,Faiella A,et al. Homeobox genes in normal and malignant cells. J Cell Physiol,2001,188:161-169.
[22]
Carrio M, Arderiu G, Myers C, et al. Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model. Cancer Res,2005,65:7177 -7185.
[23]
Scott G K, Goga A, Bhaumik D, et al. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA mir-125a or mir-125b. J Biol Chem,2007,282:1479 -1486.
[24]
Koscianska E, Baev V, Skreka K, et al. Prediction and preliminary validation of oncogene regulation by miRNAs. BMC Mol Biol,2007,8:79.
[25]
Lee Y S,Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev,2007,21:1025-1030.
[26]
Johnson S M, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 microRNA family. Cell, 2005,120:635 -647.
[27]
Yu F, Yao H, Zhu P, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell,2007,131:1109-1123.
[28]
Si M L, Zhu S, Wu H, et al. mir-21-mediated tumor growth.Oncogene,2007,26:2799 -2803.
[1] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[2] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[3] 杨柳, 宋振川, 王新乐. 乳腺癌改良根治术联合背阔肌复位的临床疗效评估[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 269-273.
[4] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[5] 宋佳, 汪波, 孙凯律, 商江峰, 吴旦平, 肇毅. 吲哚菁绿荧光显影联合亚甲蓝染色在乳腺癌前哨淋巴结活检中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 498-501.
[6] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[7] 唐丹萍, 王萍, 江孟蝶, 杨晓蓉. 自体脂肪移植在乳腺癌术后乳房重建的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 582-585.
[8] 赵小欢, 尚志英, 段文超, 张晓燕, 孙东强. 无创通气治疗COPD 并发呼吸衰竭不同预后患者外周血MicroRNA及炎性因子水平分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 777-780.
[9] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[10] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[11] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[12] 王帅, 张志远, 苏雨晴, 李雯雯, 王守凯, 刘琦, 李文涛. 孟德尔随机化及其在乳腺癌研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 671-676.
[13] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[14] 张梦婷, 穷拉姆, 色珍, 李逸群, 德庆旺姆. 西藏地区藏族乳腺癌新辅助化疗的真实世界研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 441-446.
[15] 赵阳, 肖迎聪, 巨艳, 党晓智, 蔡林利, 薛文欣, 李洋, 肖瑶, 郭妤绮, 宋宏萍. 基于自动乳腺超声的列线图模型早期预测HER-2阳性乳腺癌新辅助化疗病理完全缓解的临床价值[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 355-362.
阅读次数
全文


摘要